Protagenic Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Protagenic Therapeutics (PTIX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Protagenic Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagenic Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagenic Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $192 | 56 | 3.43 |
| 2025-06-30 | $33k | 9.0k | 3.65 |